Obermatt

AtriCure

NMQ:ATRC · US04963C2098
Health Care Equipment & SuppliesMedium

360

75
Profit price1
Owner Earnings Yield45
Dividend Yield1
Price/Sales62
EV / Gross Profit62
Price/Book51
Return on Capital33
Cash Return on Capital47
Return on Equity41
EBIT Margin29
Gross Profitability88
Accruals76
Owner Earnings Margin47
Sales growth56
Profit growth43
Reinvestment83
Price momentum48
Debt load76
Refinancing54
Debt Payback100
Liquidity52
Analyst ratings36
Opinion Changes50
Price Target Upside88
Market mood53
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

AtriCure generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNASDAQGM
Founded2000
Employees1,237
ISINUS04963C2098
Last UpdateApr 2, 2026
Themes
CardiovascularPain ManagementBiomedical EngineeringInjection MoldingNeurologySurgeryCentral Nervous SystemHealth CareMedicalMedical Device

Description

AtriCure, Inc. (AtriCure) engages in the development, manufacture, and sale of devices used by cardiothoracic and thoracic surgeons in surgical procedures, designed primarily for the surgical ablation of cardiac tissue, the exclusion of the left atri…

Analysis

Middle-of-the-road

AtriCure, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 265.4×; owner earnings: the cash an owner could take out each year.

Growth is solid; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
53
2023202420252026

All-time high

98

Jan 2025

All-time low

8

Mar 2026

Average rank

49

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
62
40
45
25
Price/Earnings
3
56
56
26
Price/Book
51
46
55
43
Dividend Yield
1
1
1
1
Value (overall)
24
37
38
17

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare AtriCure with its peers
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SI-BONE
NMQ:SIBN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
AxoGen
NAQ:AXGN
43
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Artivion
NYQ:AORT
49
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →